[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_1602 

# __Vaccine development and distribution__

## Category to which it belongs

* [Cutting-edge techniques, strategies, and technologies for pathogen detection, vaccine development, and global disease surveillance.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_195.md)

## Closest similar item

* [Development of various vaccine strategies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_835.md)
* [Rapid testing and vaccine development](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1603.md)
* [Research and development of vaccines](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1883.md)
* [Research and vaccine development](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2149.md)
* [Vaccine development](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_915.md)
* [Vaccine development and improvement technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_591.md)
* [Vaccine development and manufacturing](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1305.md)
* [Vaccine development technology](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1958.md)
* [Vaccine distribution](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1622.md)
* [Vaccine distribution to vulnerable populations](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1235.md)

## Risks linked to this technology

* [Breakthrough infections despite vaccine launch](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2085.md)
* [Lack of preexisting immunities](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3492.md)
* [Reliance on herd immunity as a control strategy for contagious diseases](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4993.md)

## This Technology belongs to this TechGroup

* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)

## This Technology belongs to this TechSubgroup

* [Vaccination development and distribution](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_66.md)

## This Technology enables the following mitigations

* [Preventive vaccines](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_3770.md)

## This technology is mentioned by

* [Ads_overview_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_404.md)
* [Ayub_graphene-based_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_378.md)
* [Contextualizing the Covid-19 pandemic for a carbon-constrained world: Insights for sustainability transitions, energy justice, and research methodology](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_123.md)

## This technology is used in the following general blueprint(s)

* [Implementing Vaccination Strategies and Awareness Campaigns](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_11.md)

